Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Preferred Stock Liabilities (2018 - 2019)

TransMedics has reported Preferred Stock Liabilities over the past 2 years, most recently at $186.5 million for Q1 2019.

  • Quarterly results put Preferred Stock Liabilities at $186.5 million for Q1 2019, changed N/A from a year ago — trailing twelve months through Mar 2019 was $186.5 million (changed N/A YoY), and the annual figure for FY2018 was $186.5 million, changed.
  • Preferred Stock Liabilities for Q1 2019 was $186.5 million at TransMedics, roughly flat from $186.5 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for TMDX hit a ceiling of $186.5 million in Q4 2018 and a floor of $186.5 million in Q4 2018.